Natural Phenomenon or Process – Page 11

Biogen’s Higher Dose Spinraza Shows Enhanced Efficacy in Treating Spinal Muscular Atrophy

11 months ago talkbio0Tagged Biogen, Clinical Trials, DEVOTE, Dose Regimen, High, Improvement, Motor function (observable entity), Nerve Degeneration, nusinersen, Spinal Muscular Atrophy, Spinraza

Biogen, Spinraza, Nusinersen, Spinal Muscular Atrophy (SMA), Higher Dose Regimen, Clinical Trial Results, DEVOTE Study, Motor Function Improvement, Neurodegeneration Reduction

Black Diamond Therapeutics Refocuses on Lung Cancer Drug BDTX-1535 Amid Workforce Reduction

11 months ago talkbio0Tagged BDTX-1535, Black Populations, Diamond Therapeutics, Epidermal Growth Factor Receptor, Malignant neoplasm of lung, Mutation, Protein-tyrosine kinase inhibitor, Tagrisso

Black Diamond Therapeutics, workforce reduction, lung cancer drug, BDTX-1535, EGFR mutations, Tagrisso, tyrosine kinase inhibitor

Baxter’s IV Fluid Production Halted Indefinitely Due to Hurricane Helene Damage

11 months ago talkbio0Tagged Baxter International, healthcare supply chain, Helene, hospital preparedness, Hurricanes, North Carolina factory, shortage

Hurricane Helene, IV fluid shortage, Baxter International, North Carolina factory, healthcare supply chain, hospital preparedness

Relay Therapeutics Announces Additional Layoffs to Achieve $50M Annual Savings

11 months ago talkbio0Tagged cost-cutting, Industry, Relay Therapeutics

Relay Therapeutics, layoffs, cost-cutting, biotech industry, workforce reduction

Relay Therapeutics Announces 10% Workforce Reduction to Streamline Research Organization

11 months ago talkbio0Tagged Relay Therapeutics, Research Organization

Relay Therapeutics, layoffs, workforce reduction, biotech, research organization, streamlining

Pharmaceutical Giants J&J, Bayer, and Pfizer Announce Layoffs Affecting Nearly 500 Employees

11 months ago talkbio0Tagged Bayer, Biotech Layoffs, Drug Industry, Johnson & Johnson, layoffs, Pfizer

Layoffs, Pharmaceutical Industry, Johnson & Johnson, Bayer, Pfizer, Biotech Layoffs, Workforce Reduction

IGM Biosciences Undergoes Strategic Pivot to Autoimmune Diseases, Overhauls Leadership and Reduces Workforce

11 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, Changing, Immunoglobulin M, imvotamab, Leadership, strategic pivot, T cell-engaging IgM antibodies

IGM Biosciences, autoimmune diseases, strategic pivot, T cell-engaging IgM antibodies, leadership changes, workforce reduction, imvotamab, IGM-2644

Shattuck Labs Shifts Focus to IBD Drug, Discontinues CD47 Program and Reduces Workforce by 40%

12 months ago talkbio0Tagged Antibodies, CD47 Antigen, Inflammatory Bowel Diseases, Laboratory test finding, Programs - Publication Format, Shattuck, SL 325, TNFRSF25 gene

Shattuck Labs, CD47 program, workforce reduction, IBD drug, SL-325, DR3 antagonist antibody

Enanta Pharmaceuticals Achieves Breakthrough in RSV Treatment with EDP-323, Demonstrating Significant Reductions in Viral Load and Symptoms

12 months ago talkbio0Tagged Alleviation, antiviral treatment, EDP-323, Enanta, Human Challenge Study, phase 2a, Respiratory syncytial virus, Symptoms, Viral Load result

Enanta Pharmaceuticals, EDP-323, Respiratory Syncytial Virus (RSV), Antiviral Treatment, Phase 2a Human Challenge Study, Viral Load Reduction, Symptom Alleviation

Bristol Myers Squibb Continues Layoffs, Cutting 79 More Jobs in New Jersey Amid $1.5B Cost Reduction Effort

12 months ago talkbio0Tagged Drug Industry, Financial cost, Myers, New Jersey, squibb

Bristol Myers Squibb, layoffs, New Jersey, cost reduction, pharmaceutical industry